Therapeutic drug monitoring of antimicrobials

被引：16
|
作者：
Balakrishnan, Indran [1 ,2 ]
Shorten, Robert J. [2 ,3 ]
机构：
[1] Royal Free London NHS Fdn Trust, Dept Med Microbiol, London, England
[2] UCL, Ctr Clin Microbiol, Royal Free Campus, London, England
[3] Manchester Royal Infirm, Publ Hlth Lab Manchester, Oxford Rd, Manchester M13 9WL, Lancs, England
来源：
ANNALS OF CLINICAL BIOCHEMISTRY | 2016年 / 53卷 / 03期
关键词：
Antimicrobial therapy; therapeutic drug monitoring; ESCHERICHIA-COLI; DISSEMINATED CANDIDIASIS; ORAL POSACONAZOLE; BRITISH SOCIETY; AMPHOTERICIN-B; PHARMACOKINETICS; VORICONAZOLE; GENTAMICIN; VANCOMYCIN; SAFETY;
D O I：
10.1177/0004563215618981
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
As pathology services become more centralized and automated, the measurement of therapeutic antimicrobial drugs concentrations is increasingly performed in clinical biochemistry or blood science' laboratories. This review outlines key groups of antimicrobial agents: aminoglycosides, glycopeptides, antifungal agents and antituberculosis agents, their role in managing infectious diseases, and the reasons why serum concentration measurement is important.
引用
收藏
页码：333 / 346
页数：14
相关论文
共 50 条
  • [1] Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients
    Gorham, Julie
    Taccone, Fabio S.
    Hites, Maya
    ANTIBIOTICS-BASEL, 2023, 12 (07):
  • [2] Editorial for the Special Issue: "Therapeutic Drug Monitoring of Antimicrobials"
    Gijsen, Matthias
    Allegaert, Karel
    ANTIBIOTICS-BASEL, 2022, 11 (06):
  • [3] Therapeutic Drug Monitoring of Voriconazole and Posaconazole
    Hussaini, Trana
    Rueping, Maria J. G. T.
    Farowski, Fedja
    Vehreschild, Janne J.
    Cornely, Oliver A.
    PHARMACOTHERAPY, 2011, 31 (02): : 214 - 225
  • [4] Posaconazole: The Case for Therapeutic Drug Monitoring
    Howard, Susan J.
    Felton, Timothy W.
    Gomez-Lopez, Alicia
    Hope, William W.
    THERAPEUTIC DRUG MONITORING, 2012, 34 (01) : 72 - 76
  • [5] Level of Evidence for Therapeutic Drug Monitoring of Posaconazole
    Lefeuvre, Sandrine
    Jelassi, Mohammed-Larbi
    Benlmouden, Amine
    Berge, Maud
    Le Guellec, Chantal
    Billaud, Eliane M.
    THERAPIE, 2011, 66 (02): : 115 - 122
  • [6] Therapeutic Drug Monitoring of Voriconazole in AIDS Patients
    Chen, Tingting
    Wu, Shuifa
    Zhang, Huatang
    Zhang, Qingquan
    Lin, Zhiqiang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (10): : 2020 - 2026
  • [7] Clinical practice guidelines for therapeutic drug monitoring of arbekacin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
    Okada, Kenji
    Kimura, Toshimi
    Mikamo, Hiroshige
    Kasahara, Kei
    Seki, Masafumi
    Takakura, Shunji
    Tokimatsu, Issei
    Ohmagari, Norio
    Takahashi, Yoshiko
    Matsumoto, Kazuaki
    Igarashi, Masahiro
    Kobayashi, Masahiro
    Hamada, Yukihiro
    Mochizuki, Takahiro
    Kimura, Masao
    Nishi, Yoshifumi
    Tanigawara, Yusuke
    Takesue, Yoshio
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (1-2) : 1 - 5
  • [8] Antifungal therapeutic drug monitoring
    Lewis R.E.
    Current Fungal Infection Reports, 2010, 4 (3) : 158 - 167
  • [9] Therapeutic Drug Monitoring of Rufinamide
    Bentue-Ferrer, Daniele
    Tribut, Olivier
    Verdier, Marie-Clemence
    THERAPIE, 2012, 67 (02): : 161 - 165
  • [10] IMPACT OF THERAPEUTIC DRUG MONITORING OF VORICONAZOLE IN A PEDIATRIC POPULATION
    Brueggemann, Roger J. M.
    van der Linden, Jan W. M.
    Verweij, Paul E.
    Burger, David M.
    Warris, Adilia
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (06) : 533 - 534
12345